The Company provides early detection for genetic disorders from pregnancy to early childhood, and infectious disease testing for the diagnostics market. fell 1.3 in premarket trading Monday, after the diagnostics, life science and food company announced an agreement to buy life science discovery and.
The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the reproductive health, immunodiagnostics and applied genomics markets. The Discovery & Analytical Solutions segment provides products and services targeted towards the life sciences and applied markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. is a provider of products, services and solutions for the diagnostics, life sciences and applied markets. Buy Issued 11th Aug.1975 Old Vintage Stock Certificate, 100-Shares Common Stock of Perkin-Elmer Corp.